TY - JOUR
T1 - Hematopoietic Cell Transplantation in 2020
T2 - Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative
AU - Denzen, Ellen M.
AU - Majhail, Navneet S.
AU - Stickney Ferguson, Stacy
AU - Anasetti, Claudio
AU - Bracey, Arthur
AU - Burns, Linda
AU - Champlin, Richard
AU - Chell, Jeffrey
AU - Leather, Helen
AU - Lill, Michael
AU - Maziarz, Richard T.
AU - Medoff, Erin
AU - Neumann, Joyce
AU - Schmit-Pokorny, Kim
AU - Snyder, Edward L.
AU - Wiggins, Laura
AU - Yolin Raley, Deborah S.
AU - Murphy, Elizabeth A.
N1 - Funding Information:
Financial disclosure: Funding for this conference was made possible (in part) by grant 1R13HL110705-01 from the National Institutes of Health, Yale School of Medicine, Yale University and the National Marrow Donor Program . The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the US Government. The authors have no conflicts of interest to disclose.
PY - 2013/1
Y1 - 2013/1
N2 - The National Marrow Donor Program, in partnership with the American Society for Blood and Marrow Transplantation, sponsored and organized a series of symposia to identify complex issues affecting the delivery of hematopoietic cell transplantation (HCT) and to collaboratively develop options for solutions. " Hematopoietic Cell Transplantation in 2020: A System Capacity Initiative" used a deliberative process model to engage professional organizations, experts, transplant centers, and stakeholders in a national collaborative effort. Year 2 efforts emphasized data analysis and identification of innovative ideas to increase HCT system efficiency, address future capacity requirements, and ensure adequate reimbursement for HCT programs to meet the projected need for HCT. This report highlights the deliberations and recommendations of Year 2 and the associated symposium held in September 2011.
AB - The National Marrow Donor Program, in partnership with the American Society for Blood and Marrow Transplantation, sponsored and organized a series of symposia to identify complex issues affecting the delivery of hematopoietic cell transplantation (HCT) and to collaboratively develop options for solutions. " Hematopoietic Cell Transplantation in 2020: A System Capacity Initiative" used a deliberative process model to engage professional organizations, experts, transplant centers, and stakeholders in a national collaborative effort. Year 2 efforts emphasized data analysis and identification of innovative ideas to increase HCT system efficiency, address future capacity requirements, and ensure adequate reimbursement for HCT programs to meet the projected need for HCT. This report highlights the deliberations and recommendations of Year 2 and the associated symposium held in September 2011.
KW - Allogeneic transplant
KW - Care delivery model
KW - Healthcare disparities
KW - Reimbursement
KW - Workforce
UR - http://www.scopus.com/inward/record.url?scp=84871917059&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871917059&partnerID=8YFLogxK
U2 - 10.1016/j.bbmt.2012.10.005
DO - 10.1016/j.bbmt.2012.10.005
M3 - Article
C2 - 23078785
AN - SCOPUS:84871917059
SN - 1083-8791
VL - 19
SP - 4
EP - 11
JO - Biology of Blood and Marrow Transplantation
JF - Biology of Blood and Marrow Transplantation
IS - 1
ER -